| Year |
Citation |
Score |
| 2020 |
Adams SF, Grimm AJ, Chiang CL, Mookerjee A, Flies D, Jean S, McCann GA, Michaux J, Pak H, Huber F, Neal C, Dangaj D, Bassani-Sternberg M, Rusakiewicz S, Facciabene A, ... ... Gimotty PA, et al. Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes. Journal For Immunotherapy of Cancer. 8. PMID 32817208 DOI: 10.1136/Jitc-2020-000875 |
0.317 |
|
| 2020 |
Sharma G, Ojha R, Noguera-Ortega E, Rebecca VW, Attanasio J, Liu S, Piao S, Lee JJ, Nicastri MC, Harper SL, Ronghe A, Jain V, Winkler JD, Speicher DW, Mastio J, ... Gimotty PA, et al. PPT1 Inhibition enhances the anti-tumor activity of anti-PD-1 antibody in melanoma. Jci Insight. PMID 32780726 DOI: 10.1172/Jci.Insight.133225 |
0.347 |
|
| 2020 |
Sinnamon AJ, Gimotty PA, Karakousis GC, Yang YX. Survival Outcomes Following Lymph Node Biopsy in Thin Melanoma-A Propensity-Matched Analysis. Annals of Surgical Oncology. PMID 32779048 DOI: 10.1245/S10434-020-08997-3 |
0.329 |
|
| 2020 |
Modi MB, Gimotty PA, Ming ME, Jariwala N, Elenitsas R, Miller C, Chu EY, Lindner H, Moshiri AS, Schwartz LE, Lal P, Reyes MC, Elder DE, Xu X. Urethral involvement is associated with higher mortality and local recurrence in vulvar melanoma: a single institutional experience. Human Pathology. PMID 32702401 DOI: 10.1016/J.Humpath.2020.07.017 |
0.369 |
|
| 2020 |
Facompre ND, Rajagopalan P, Sahu V, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Weinstein GS, Jalaly J, Lin A, Rustgi AK, Nakagawa H, Califano JA, Pickering CR, White EA, ... ... Gimotty PA, et al. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models. International Journal of Cancer. PMID 32478869 DOI: 10.1002/Ijc.33125 |
0.308 |
|
| 2020 |
Song Y, Straker RJ, Xu X, Elder DE, Gimotty PA, Huang AC, Mitchell TC, Amaravadi RK, Schuchter LM, Karakousis GC. Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma. Annals of Surgical Oncology. PMID 31898103 DOI: 10.1245/S10434-019-08174-1 |
0.32 |
|
| 2020 |
Facompre ND, Rajagopalan P, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Nakagawa H, White EA, Rustgi AK, Califano JA, Pickering CR, Windle B, Morgan IM, Gimotty PA, Basu D. Abstract A01: HPV+ oral cancer PDXs identify prognostic utility for E2F target gene expression and mutation burden Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-A01 |
0.311 |
|
| 2019 |
Kwak M, Song Y, Gimotty PA, Farrow NE, Tieniber AD, Davick JG, Tortorello GN, Beasley GM, Slingluff CL, Karakousis GC. Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis. Annals of Surgical Oncology. PMID 31392529 DOI: 10.1245/S10434-019-07694-0 |
0.349 |
|
| 2019 |
Song Y, Tieniber AD, Gimotty PA, Mitchell TC, Amaravadi RK, Schuchter LM, Fraker DL, Karakousis GC. Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies. Annals of Surgical Oncology. PMID 31270717 DOI: 10.1245/S10434-019-07599-Y |
0.352 |
|
| 2019 |
Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ, Gimotty PA, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 35: 885-900.e10. PMID 31185212 DOI: 10.1016/J.Ccell.2019.05.004 |
0.347 |
|
| 2019 |
Yun SJ, Liu S, Buckley M, Wang T, Jin S, Karakousis G, Peters MG, Elder DE, Gimotty PA, Xu X. Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma. Human Pathology. PMID 30965022 DOI: 10.1016/J.Humpath.2019.03.008 |
0.402 |
|
| 2019 |
Haas NB, Appleman LJ, Stein M, Redlinger M, Wilks M, Xu X, Onorati A, Kalavacharla A, Kim T, Zhen CJ, Kadri S, Segal JP, Gimotty PA, Davis LE, Amaravadi RK. Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30635337 DOI: 10.1158/1078-0432.Ccr-18-2204 |
0.332 |
|
| 2019 |
Gimotty PA, Karakousis G, Buckley MA, Guerry D. A population-based model for predicting sentinel lymph node (SLN) status for cutaneous melanoma patients and a clinical decision rule (CDR) for sparing a SLN biopsy (SLNB). Journal of Clinical Oncology. 37: 9589-9589. DOI: 10.1200/Jco.2019.37.15_Suppl.9589 |
0.306 |
|
| 2019 |
Ayers EC, Margolis DJ, Gimotty PA, Landsburg DJ. Real World Outcomes of Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation and Receive Commercially-Available Salvage Therapy Blood. 134: 2893-2893. DOI: 10.1182/Blood-2019-128815 |
0.309 |
|
| 2019 |
McCurdy SR, Gier SH, Babushok DV, Frey NV, Gill SI, Hexner EO, Loren AW, Mangan JK, Martin ME, Perl AE, Maillard I, Pratz KW, Porter DL, Carroll MP, Gimotty PA, et al. Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome Blood. 134: 2209-2209. DOI: 10.1182/Blood-2019-124468 |
0.306 |
|
| 2018 |
Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A, McAfee Q, McLaughlin NP, Zhang G, Goldman AR, Ojha R, Piao S, Noguera-Ortega E, Martorella A, Alicea GM, ... ... Gimotty PA, et al. PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discovery. PMID 30442709 DOI: 10.1158/2159-8290.Cd-18-0706 |
0.37 |
|
| 2018 |
Karakousis GC, Gimotty PA, Leong SP, Pockaj BA, White RL, O'Donoghue C, Sinnamon AJ, Bartlett EK, Dueck AC, Gould Rothberg BE, Messina JL, Vetto JT, Sondak VK, Schneebaum S, Kashani-Sabet M, et al. Microsatellitosis in Patients with Melanoma. Annals of Surgical Oncology. PMID 30421045 DOI: 10.1245/S10434-018-7006-4 |
0.344 |
|
| 2018 |
Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, Upadhyay P, Uyeminami DL, Pommier A, Küttner V, Bružas E, Maiorino L, Bautista C, Carmona EM, Gimotty PA, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science (New York, N.Y.). 361. PMID 30262472 DOI: 10.1126/Science.Aao4227 |
0.365 |
|
| 2018 |
Sinnamon AJ, Gimotty PA, Karakousis GC. Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma-Reply. Jama Oncology. PMID 29902301 DOI: 10.1001/Jamaoncol.2018.0898 |
0.315 |
|
| 2018 |
Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville T, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, ... ... Gimotty PA, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery. PMID 29853643 DOI: 10.1158/2159-8290.Cd-18-0349 |
0.359 |
|
| 2018 |
Sinnamon AJ, Sharon CE, Song Y, Neuwirth MG, Elder DE, Xu X, Chu EY, Ming ME, Fraker DL, Gimotty PA, Karakousis GC. The Prognostic Significance of Tumor-Infiltrating Lymphocytes for Primary Melanoma Varies by Sex. Journal of the American Academy of Dermatology. PMID 29518458 DOI: 10.1016/J.Jaad.2018.02.066 |
0.326 |
|
| 2018 |
Facompre ND, Harmeyer KM, Sahu V, Gimotty PA, Rustgi AK, Nakagawa H, Basu D. Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer. Oncotarget. 9: 8985-8998. PMID 29507668 DOI: 10.18632/Oncotarget.23739 |
0.341 |
|
| 2018 |
Abbott J, Buckley M, Taylor LA, Xu G, Karakousis G, Czerniecki BJ, Gimotty PA, Zhang PJ. Histological Immune Response Patterns in Sentinel Lymph Nodes Involved by Metastatic Melanoma and Prognostic Significance. Journal of Cutaneous Pathology. PMID 29446846 DOI: 10.1111/Cup.13127 |
0.309 |
|
| 2018 |
Pishko A, Lefler D, Gimotty P, Guevara J, Cuker A. The Risk of Major Bleeding in Patients with Suspected Heparin-Induced Thrombocytopenia (HIT) Blood. 132: 377-377. DOI: 10.1182/Blood-2018-99-112200 |
0.319 |
|
| 2017 |
Sinnamon AJ, Neuwirth MG, Gimotty PA, Gangadhar TC, Amaravadi RK, Schuchter LM, Karakousis GC. Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma. Jama Oncology. PMID 29145547 DOI: 10.1001/Jamaoncol.2017.3462 |
0.314 |
|
| 2017 |
Yam C, Xu X, Davies MA, Gimotty PA, Morrissette JJ, Tetzlaff MT, Wani K, Liu S, Deng W, Buckley M, Zhao J, Amaravadi RK, Haas N, Kudchadkar RR, Pavlick A, et al. A multicenter phase I study evaluating dual PI3K and BRAF inhibition with PX-866 and vemurafenib in patients with advanced BRAF V600 mutant solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29051322 DOI: 10.1158/1078-0432.Ccr-17-1807 |
0.307 |
|
| 2017 |
Piao S, Ojha R, Rebecca VW, Samanta A, Ma XH, Mcafee Q, Nicastri MC, Buckley M, Brown E, Winkler JD, Gimotty PA, Amaravadi RK. ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells. Autophagy. 1-16. PMID 28981387 DOI: 10.1080/15548627.2017.1377377 |
0.366 |
|
| 2017 |
Sinnamon AJ, Neuwirth MG, Yalamanchi P, Gimotty P, Elder DE, Xu X, Kelz RR, Roses RE, Chu EY, Ming ME, Fraker DL, Karakousis GC. Association Between Patient Age and Lymph Node Positivity in Thin Melanoma. Jama Dermatology. PMID 28724122 DOI: 10.1001/Jamadermatol.2017.2497 |
0.325 |
|
| 2016 |
Flies DB, Higuchi T, Harris JC, Jha V, Gimotty PA, Adams SF. Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer. Oncoimmunology. 5: e1185583. PMID 27622059 DOI: 10.1080/2162402X.2016.1185583 |
0.367 |
|
| 2016 |
Facompre ND, Harmeyer KM, Sole X, Kabraji S, Belden Z, Sahu V, Whelan K, Tanaka K, Weinstein GS, Montone KT, Roesch A, Gimotty PA, Herlyn M, Rustgi AK, Nakagawa H, et al. JARID1B enables transit between distinct states of the stem-like cell population in oral cancers. Cancer Research. PMID 27488530 DOI: 10.1158/0008-5472.Can-15-3377 |
0.319 |
|
| 2016 |
Kumar AJ, Gimotty PA, Gelfand J, Buck G, Rowe JM, Goldstone AH, Fielding A, Marks DI, Litzow M, Paietta E, Lazarus HM, Tallman MS, Luger SM, Loren AW. Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Transplant: An Analysis from ECOG 2993/MRC UK ALLXII. American Journal of Hematology. PMID 27468137 DOI: 10.1002/Ajh.24497 |
0.309 |
|
| 2016 |
Shannan B, Watters A, Chen Q, Mollin S, Dörr M, Meggers E, Xu X, Gimotty PA, Perego M, Li L, Benci J, Krepler C, Brafford P, Zhang J, Wei Z, et al. PIM kinases as therapeutic targets against advanced melanoma. Oncotarget. PMID 27448973 DOI: 10.18632/Oncotarget.10703 |
0.375 |
|
| 2016 |
Gimotty PA, Shore R, Lozon N, Whitlock J, He S, Vigneau FD, Dickie L, Elder DE, Xu X, Schwartz AG, Guerry D. Miscoding of melanoma thickness in SEER: Research and clinical implications. The Journal of Investigative Dermatology. PMID 27354265 DOI: 10.1016/J.Jid.2016.05.121 |
0.339 |
|
| 2016 |
Sloan CE, Luskin MR, Boccuti AM, Sehgal AR, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Gimotty PA, Carroll M. A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia. Plos One. 11: e0153016. PMID 27050425 DOI: 10.1371/Journal.Pone.0153016 |
0.308 |
|
| 2016 |
Piao S, Samanta A, Ma X, Mcafee QW, Rebecca VW, Buckley M, Brown EJ, Gimotty PA, Amaravadi RK. Abstract 1024: Expression pattern of ALDH1A1 and HLTF predicts sensitivity to lysosomal autophagy inhibitors in cancer cells Cancer Research. 76: 1024-1024. DOI: 10.1158/1538-7445.Am2016-1024 |
0.353 |
|
| 2015 |
Bartlett EK, Peters MG, Blair A, Etherington MS, Elder DE, Xu XG, Guerry D, Ming ME, Fraker DL, Czerniecki BJ, Gimotty PA, Karakousis GC. Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity. Annals of Surgical Oncology. PMID 26215202 DOI: 10.1245/S10434-015-4766-Y |
0.346 |
|
| 2015 |
Higuchi T, Flies DB, Marjon NA, Mantia-Smaldone G, Ronner L, Gimotty PA, Adams SF. CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer. Cancer Immunology Research. 3: 1257-68. PMID 26138335 DOI: 10.1158/2326-6066.Cir-15-0044 |
0.368 |
|
| 2015 |
Kraya AA, Piao S, Xu X, Zhang G, Herlyn M, Gimotty P, Levine B, Amaravadi RK, Speicher DW. Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy. 11: 60-74. PMID 25484078 DOI: 10.4161/15548627.2014.984273 |
0.351 |
|
| 2015 |
Vultur AM, Shannan B, Chen Q, Watters A, Mollin S, Meggers E, Krepler C, Perego M, Li L, Gimotty PA, Xu X, Herlyn M. Abstract 687: Compound screen identifies PIM kinases as therapeutic targets for melanoma Cancer Research. 75: 687-687. DOI: 10.1158/1538-7445.Am2015-687 |
0.338 |
|
| 2015 |
Facompre N, Belden Z, Gimotty P, Rustgi A, Herlyn M, Nakagawa H, Basu D. Abstract 1517: G0-like cells support an oral cancer stem cell pool by transitioning to a JARID1B-high state Cancer Research. 75: 1517-1517. DOI: 10.1158/1538-7445.Am2015-1517 |
0.333 |
|
| 2014 |
Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S. The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model. Gynecologic Oncology. 133: 584-90. PMID 24680909 DOI: 10.1016/J.Ygyno.2014.03.565 |
0.361 |
|
| 2014 |
Balch CM, Thompson JF, Gershenwald JE, Soong SJ, Ding S, McMasters KM, Coit DG, Eggermont AMM, Gimotty PA, Johnson TM, Kirkwood JM, Leong SP, Ross MI, Byrd DR, Cochran AJ, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: An inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients Annals of Surgical Oncology. 21: 1075-1081. PMID 24531700 DOI: 10.1245/S10434-013-3464-X |
0.36 |
|
| 2014 |
Xu X, Gimotty PA, Guerry D, Karakousis G, Elder DE. Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma. Methods in Molecular Biology (Clifton, N.J.). 1102: 275-86. PMID 24258984 DOI: 10.1007/978-1-62703-727-3_15 |
0.354 |
|
| 2014 |
Bartlett EK, Gupta M, Datta J, Gimotty PA, Guerry D, Xu X, Elder DE, Czerniecki BJ, Fraker DL, Karakousis GC. Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy. Annals of Surgical Oncology. 21: 1016-23. PMID 24258854 DOI: 10.1245/S10434-013-3388-5 |
0.34 |
|
| 2014 |
Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, Xu X, Elder DE, Ming M, Elenitsas R, Guerry D, Kelz RR, Czerniecki BJ, Fraker DL, Karakousis GC. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy. Annals of Surgical Oncology. 21: 643-9. PMID 24121883 DOI: 10.1245/S10434-013-3313-Y |
0.323 |
|
| 2014 |
Vultur A, Villanueva J, Krepler C, Rajan G, Chen Q, Xiao M, Li L, Gimotty PA, Wilson M, Hayden J, Keeney F, Nathanson KL, Herlyn M. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines Oncogene. 33: 1850-1861. PMID 23624919 DOI: 10.1038/Onc.2013.131 |
0.322 |
|
| 2014 |
Gimotty PA, Shore RD, Guerry D. Prognosis of patients with very thin cutaneous melanoma: The good, the bad, and the miscoded. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E20044 |
0.356 |
|
| 2014 |
Sloan CE, Gimotty PA, Boccuti AM, Sehgal A, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Carroll M. Predicting prognosis in patients with acute myeloid leukemia: The role of next-generation sequencing and mutational profiling. Journal of Clinical Oncology. 32: 7068-7068. DOI: 10.1200/Jco.2014.32.15_Suppl.7068 |
0.323 |
|
| 2014 |
Luskin MR, Gimotty PA, Wertheim G, Smith C, Sehgal AR, Luger SM, Master SR, Loren AW, Carroll MP. A Measure of DNA Methylation for Predicting Outcome in De Novo AML Blood. 124: 2345-2345. DOI: 10.1182/Blood.V124.21.2345.2345 |
0.303 |
|
| 2014 |
Kumar AJ, Gimotty PA, Gelfand J, Buck G, Rowe JM, Goldstone AH, Fielding A, Marks DI, Litzow M, Paietta E, Lazarus HM, Tallman MS, Luger SM, Loren AW. Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT) Blood. 124: 208-208. DOI: 10.1182/Blood.V124.21.208.208 |
0.345 |
|
| 2014 |
Sloan CE, Gimotty PA, Boccuti A, Sehgal AR, Zhao J, Daber R, Morrissette JJ, Luger SM, Bagg A, Carroll MP. Next Generation Mutational Profiling Improves Prognostication in Younger Patients with Acute Myeloid Leukemia Blood. 124: 1032-1032. DOI: 10.1182/Blood.V124.21.1032.1032 |
0.346 |
|
| 2013 |
Basu D, Bewley AF, Sperry SM, Montone KT, Gimotty PA, Rasanen K, Facompre ND, Weinstein GS, Nakagawa H, Diehl JA, Rustgi AK, Herlyn M. EGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomas. Molecular Cancer Therapeutics. 12: 2176-86. PMID 23939378 DOI: 10.1158/1535-7163.Mct-12-1210 |
0.354 |
|
| 2013 |
Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Coit DG, Atkins MB, Ding S, Cochran AJ, Eggermont AMM, Flaherty KT, Gimotty PA, Johnson TM, Kirkwood JM, Leong SP, McMasters KM, et al. Age as a prognostic factor in patients with localized melanoma and regional metastases Annals of Surgical Oncology. 20: 3961-3968. PMID 23838920 DOI: 10.1245/S10434-013-3100-9 |
0.363 |
|
| 2013 |
Cintolo JA, Gimotty P, Blair A, Guerry D, Elder DE, Hammond R, Elenitsas R, Xu X, Fraker D, Schuchter LM, Czerniecki BJ, Karakousis G. Local immune response predicts survival in patients with thick (t4) melanomas. Annals of Surgical Oncology. 20: 3610-7. PMID 23838911 DOI: 10.1245/S10434-013-3086-3 |
0.368 |
|
| 2013 |
Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, Körbel C, Laschke MW, Gimotty PA, Philipp SE, Krause E, Pätzold S, Villanueva J, Krepler C, Fukunaga-Kalabis M, et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 23: 811-25. PMID 23764003 DOI: 10.1016/J.Ccr.2013.05.003 |
0.325 |
|
| 2013 |
Wong GS, Habibollahi P, Heidari P, Lee JS, Klein-Szanto AJ, Waldron TJ, Gimotty P, Nakagawa H, Taylor PR, Wang TC, Mahmood U, Rustgi AK. Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology. 144: 294-7. PMID 23085486 DOI: 10.1053/J.Gastro.2012.10.030 |
0.323 |
|
| 2013 |
Balint K, Seedial T, Gimotty P, Coukos G, Facciabene A. Abstract 1421: Interleukin-22, a protective factor for ovarian cancer during TNFa-induced apoptosis. Cancer Research. 73: 1421-1421. DOI: 10.1158/1538-7445.Am2013-1421 |
0.315 |
|
| 2013 |
Kagawa S, Nakagawa K, Natsuizaka M, Kinugasa H, Whelan KA, Chang S, Subramanian H, Ohashi S, Klein-Szanto AJ, Gimotty PA, Diehl JA, Herlyn M, Nakagawa H, Rustgi AK. 677 Inactivation of the Retinoblastoma Protein-Dependent Senescence Checkpoint Functions Permits Notch1 to Gain Oncogenic Tumor Promoting Activity Gastroenterology. 144: S-124. DOI: 10.1016/S0016-5085(13)60444-8 |
0.336 |
|
| 2013 |
Natsuizaka M, Kagawa S, Whelan KA, Chang S, Kinugasa H, Ohashi S, Naganuma S, Sakamoto N, Klein-Szanto AJ, Gimotty PA, Diehl JA, Herlyn M, Rustgi AK, Nakagawa H. 237 Transforming Growth Factor-β and Notch1 Cooperate to Repress NOTCH3 to Facilitate Epithelial-Mesenchymal Transition and Tumor Initiating Capability in Esophageal Squamous Cell Carcinoma Gastroenterology. 144: S-52. DOI: 10.1016/S0016-5085(13)60183-3 |
0.306 |
|
| 2012 |
Nunez-Cruz S, Gimotty PA, Guerra MW, Connolly DC, Wu YQ, DeAngelis RA, Lambris JD, Coukos G, Scholler N. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. Neoplasia (New York, N.Y.). 14: 994-1004. PMID 23226093 DOI: 10.1593/Neo.121262 |
0.344 |
|
| 2012 |
Yang K, Mooney C, Spahlinger G, Schuetze S, Arias-Pulido H, Verschraegen C, Gimotty P, Buckanovich RJ. DR6 as a diagnostic and predictive biomarker in adult sarcoma. Plos One. 7: e36525. PMID 22567163 DOI: 10.1371/Journal.Pone.0036525 |
0.306 |
|
| 2012 |
Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W, Xu X. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 31: 4898-911. PMID 22286766 DOI: 10.1038/Onc.2011.656 |
0.386 |
|
| 2012 |
Xu X, Chen L, Guerry D, Dawson PR, Hwang WT, VanBelle P, Elder DE, Zhang PJ, Ming ME, Schuchter L, Gimotty PA. Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 229-37. PMID 22096024 DOI: 10.1158/1078-0432.Ccr-11-0490 |
0.553 |
|
| 2012 |
Tang HY, Beer LA, Chang-Wong T, Hammond R, Gimotty P, Coukos G, Speicher DW. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer. Journal of Proteome Research. 11: 678-91. PMID 22032327 DOI: 10.1021/Pr200603H |
0.34 |
|
| 2012 |
Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH. Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunology, Immunotherapy : Cii. 61: 629-41. PMID 22021066 DOI: 10.1007/S00262-011-1081-8 |
0.306 |
|
| 2012 |
Gamerman V, Karakousis GC, Guerry D, Gimotty PA. Conditional survival (CS) in patients with stage II melanoma. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E19054 |
0.353 |
|
| 2012 |
Natsuizaka M, Chang S, Kagawa S, Naganuma S, Ohashi S, Whelan KA, Wong GS, Vega ME, Yang Y, Gimotty PA, Diehl JA, Herlyn M, Nakagawa H. 252 CD44 Defines Highly Plastic Esophageal Squamous Cancer Cells With Tumor Initiating Capabilities Gastroenterology. 142: S-59. DOI: 10.1016/S0016-5085(12)60230-3 |
0.329 |
|
| 2011 |
Ohashi S, Natsuizaka M, Naganuma S, Kagawa S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, Gimotty PA, Klein-Szanto AJ, Diehl JA, Herlyn M, Nakagawa H. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Research. 71: 6836-47. PMID 21890822 DOI: 10.1158/0008-5472.Can-11-0846 |
0.348 |
|
| 2011 |
Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ, Feldman MD, Coukos G. Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer Biology & Therapy. 12: 367-77. PMID 21785280 DOI: 10.4161/Cbt.12.4.16908 |
0.398 |
|
| 2011 |
Hagemann AR, Cadungog M, Hagemann IS, Hammond R, Adams SF, Chu CS, Rubin SC, Zhang L, Addya K, Birrer MJ, Gimotty PA, Coukos G. Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment. Cancer Biology & Therapy. 12: 357-66. PMID 21785264 DOI: 10.4161/Cbt.12.4.16951 |
0.329 |
|
| 2011 |
Huang J, Zhang L, Greshock J, Colligon TA, Wang Y, Ward R, Katsaros D, Lassus H, Butzow R, Godwin AK, Testa JR, Nathanson KL, Gimotty PA, Coukos G, Weber BL, et al. Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes, Chromosomes & Cancer. 50: 606-18. PMID 21563232 DOI: 10.1002/Gcc.20883 |
0.385 |
|
| 2011 |
Basu D, Montone KT, Wang LP, Gimotty PA, Hammond R, Diehl JA, Rustgi AK, Lee JT, Rasanen K, Weinstein GS, Herlyn M. Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle (Georgetown, Tex.). 10: 2008-16. PMID 21558812 DOI: 10.4161/Cc.10.12.15883 |
0.359 |
|
| 2011 |
Yun SJ, Gimotty PA, Hwang WT, Dawson P, Van Belle P, Elder DE, Elenitsas R, Schuchter L, Zhang PJ, Guerry D, Xu X. High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma. The American Journal of Surgical Pathology. 35: 235-42. PMID 21263244 DOI: 10.1097/Pas.0B013E3182036Ccd |
0.549 |
|
| 2011 |
Krepler C, Chunduru SK, He X, Gimotty PA, Vultur A, Villanueva J, Herlyn M. Abstract 5480: Effect of the Smac mimetic TL32711 in combination with TRAIL or TNF alpha on a panel of melanoma cell lines Cancer Research. 71: 5480-5480. DOI: 10.1158/1538-7445.Am2011-5480 |
0.336 |
|
| 2010 |
Ma X, Kundu N, Ioffe OB, Goloubeva O, Konger R, Baquet C, Gimotty P, Reader J, Fulton AM. Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities. Molecular Cancer Research : McR. 8: 1310-8. PMID 20858737 DOI: 10.1158/1541-7786.Mcr-10-0003 |
0.365 |
|
| 2010 |
Michaylira CZ, Wong GS, Miller CG, Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim SB, Herlyn M, Diehl JA, Gimotty P, Rustgi AK. Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. Cancer Research. 70: 5281-92. PMID 20516120 DOI: 10.1158/0008-5472.Can-10-0704 |
0.387 |
|
| 2010 |
Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 141: 583-94. PMID 20478252 DOI: 10.1016/J.Cell.2010.04.020 |
0.374 |
|
| 2010 |
Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Research : Bcr. 12: R26. PMID 20459744 DOI: 10.1186/Bcr2570 |
0.328 |
|
| 2010 |
Rustgi AK, Stairs DB, Grugan KD, Wong GS, Vega ME, Kalabis J, Nakagawa H, Gimotty PA, Klein-Szanto AJ, Diehl JA, Herlyn M. Abstract CN04-03: Esophageal cancer and the tumor microenvironment Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Cn04-03 |
0.357 |
|
| 2010 |
Natsuizaka M, Kalman RA, Ohashi S, Takaoka M, Gimotty P, El-Deiry WS, Klein-Szanto A, Diehl JA, Herlyn M, Nakagawa H. Abstract 2294: IGF-independent regulation of EMT by insulin-like growth factor binding protein-3 in transformed human esophageal cells Cancer Research. 70: 2294-2294. DOI: 10.1158/1538-7445.Am10-2294 |
0.366 |
|
| 2010 |
Naganuma S, Ohashi S, Kimura S, Natsuizaka M, Gimotty P, Klein-Szanto AJ, Itoh H, Nakagawa H. Abstract 2293: ZEB1 and ZEB2 promote EMT and invasion in esophageal squamous cell carcinoma Cancer Research. 70: 2293-2293. DOI: 10.1158/1538-7445.Am10-2293 |
0.339 |
|
| 2009 |
Yun S, Gimotty P, Hwang W, Dawson P, VanBelle P, Elder D, Elenitsas R, Guerry D, Schuchter L, Xu X. The biology and prognostic value of lymphatic vessel density (LD) and lymphatic invasion (LI) in regression in melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9017. PMID 27962378 DOI: 10.1200/Jco.2009.27.15_Suppl.9017 |
0.332 |
|
| 2009 |
Xu X, Chen L, Hwang W, Dawson P, Guerry D, VanBelle P, Elder D, Schuchter L, Gimotty P. The prognostic significance of lymphatic invasion in primary melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9050. PMID 27962127 DOI: 10.1200/Jco.2009.27.15_Suppl.9050 |
0.361 |
|
| 2009 |
Gimotty P, Guerry D, VanBelle P, Montone K, Guerra M, Hwang W, Schuchter L, Xu X, Elder D. Ki67 as a prognostic biomarker for patients with vertical growth phase (VGP) melanomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9043. PMID 27962110 DOI: 10.1200/Jco.2009.27.15_Suppl.9043 |
0.377 |
|
| 2009 |
Alagkiozidis I, Facciabene A, Carpenito C, Benencia F, Jonak Z, Adams S, Carroll RG, Gimotty PA, Hammond R, Danet-Desnoyers GÄ, June CH, Powell DJ, Coukos G. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of Translational Medicine. 7: 104. PMID 20003308 DOI: 10.1186/1479-5876-7-104 |
0.363 |
|
| 2009 |
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, et al. Final version of 2009 AJCC melanoma staging and classification Journal of Clinical Oncology. 27: 6199-6206. PMID 19917835 DOI: 10.1200/Jco.2009.23.4799 |
0.375 |
|
| 2009 |
Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, Katsaros D, Coukos G, Zhang L, Huang Q. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nature Cell Biology. 11: 1297-304. PMID 19801974 DOI: 10.1038/Ncb1974 |
0.344 |
|
| 2009 |
Adams SF, Levine DA, Cadungog MG, Hammond R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA, Coukos G. Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer. Cancer. 115: 2891-902. PMID 19472394 DOI: 10.1002/Cncr.24317 |
0.399 |
|
| 2009 |
Yu H, McDaid R, Lee J, Possik P, Li L, Kumar SM, Elder DE, Van Belle P, Gimotty P, Guerra M, Hammond R, Nathanson KL, Dalla Palma M, Herlyn M, Xu X. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. The American Journal of Pathology. 174: 2367-77. PMID 19389934 DOI: 10.2353/Ajpath.2009.081057 |
0.337 |
|
| 2009 |
Ma X, Norsworthy K, Kundu N, Rodgers WH, Gimotty PA, Goloubeva O, Lipsky M, Li Y, Holt D, Fulton A. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Molecular Cancer Therapeutics. 8: 490-8. PMID 19276169 DOI: 10.1158/1535-7163.Mct-08-0485 |
0.405 |
|
| 2008 |
Xu X, Gimotty PA, Guerry D, Karakousis G, Van Belle P, Liang H, Montone K, Pasha T, Ming ME, Acs G, Feldman M, Barth S, Hammond R, Elenitsas R, Zhang PJ, et al. Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Human Pathology. 39: 901-9. PMID 18440591 DOI: 10.1016/J.Humpath.2007.10.017 |
0.363 |
|
| 2008 |
Gimotty PA, Guerry D, Flaherty K. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 517-8. PMID 18235111 DOI: 10.1200/Jco.2007.14.3156 |
0.368 |
|
| 2008 |
Holtz DO, Krafty RT, Mohamed-Hadley A, Zhang L, Alagkiozidis I, Leiby B, Guo W, Gimotty PA, Coukos G. Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer. Journal of Translational Medicine. 6: 2. PMID 18182107 DOI: 10.1186/1479-5876-6-2 |
0.321 |
|
| 2008 |
Wondimu A, Zhang T, Kieber-Emmons T, Gimotty P, Sproesser K, Somasundaram R, Ferrone S, Tsao CY, Herlyn D. Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunology, Immunotherapy : Cii. 57: 1079-89. PMID 18157673 DOI: 10.1007/S00262-007-0439-4 |
0.313 |
|
| 2008 |
Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature Medicine. 14: 28-36. PMID 18157142 DOI: 10.1038/Nm1699 |
0.377 |
|
| 2008 |
Edwards R, Guerry D, Piris A, Elenitsas R, Seykora J, Schuchter L, Mihm M, Xu X, Gimotty P. Phospho-ERK (pERK) and Ki67 expression as compared to thickness and mitotic rate (MR) as prognostic factors in patients with stage I/II melanomas Journal of Clinical Oncology. 26: 9020-9020. DOI: 10.1200/Jco.2008.26.15_Suppl.9020 |
0.412 |
|
| 2008 |
Gimotty P, Yoon F, Hammond R, Rosenbaum P, Guerry D. Sentinel lymph node biopsy (SLNB) improves survival among SEER patients with melanoma Journal of Clinical Oncology. 26: 9005-9005. DOI: 10.1200/Jco.2008.26.15_Suppl.9005 |
0.365 |
|
| 2007 |
Swoboda RK, Somasundaram R, Caputo L, Ochoa EM, Gimotty PA, Marincola FM, Van Belle P, Barth S, Elder D, Guerry D, Czerniecki B, Schuchter L, Vonderheide RH, Herlyn D. Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display. Cancer Research. 67: 3555-9. PMID 17440064 DOI: 10.1158/0008-5472.Can-06-2763 |
0.33 |
|
| 2007 |
Gumireddy K, Sun F, Klein-Szanto AJ, Gibbins JM, Gimotty PA, Saunders AJ, Schultz PG, Huang Q. In vivo selection for metastasis promoting genes in the mouse. Proceedings of the National Academy of Sciences of the United States of America. 104: 6696-701. PMID 17420453 DOI: 10.1073/Pnas.0701145104 |
0.368 |
|
| 2007 |
Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 1129-34. PMID 17369575 DOI: 10.1200/Jco.2006.08.1463 |
0.366 |
|
| 2007 |
Buckanovich RJ, Sasaroli D, O'Brien-Jenkins A, Botbyl J, Hammond R, Katsaros D, Sandaltzopoulos R, Liotta LA, Gimotty PA, Coukos G. Tumor vascular proteins as biomarkers in ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 852-61. PMID 17327606 DOI: 10.1200/Jco.2006.08.8583 |
0.359 |
|
| 2007 |
Karakousis GC, Gimotty PA, Czerniecki BJ, Elder DE, Elenitsas R, Ming ME, Fraker DL, Guerry D, Spitz FR. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients. Annals of Surgical Oncology. 14: 1596-603. PMID 17285396 DOI: 10.1245/S10434-006-9319-Y |
0.356 |
|
| 2007 |
Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood. 109: 3409-16. PMID 17179223 DOI: 10.1182/Blood-2006-09-047621 |
0.328 |
|
| 2007 |
Spatz A, Gimotty PA, Cook MG, van den Oord JJ, Desai N, Eggermont AM, Keilholz U, Ruiter DJ, Mihm MC. Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study Journal of Clinical Oncology. 25: 8519-8519. DOI: 10.1200/Jco.2007.25.18_Suppl.8519 |
0.404 |
|
| 2007 |
Gor PP, Gray RJ, Horn M, Rebbeck TR, Gimotty PA, Aplenc R, Pins M, Tallman MS, DeMichele A. Association of polymorphic drug metabolizing enzymes (DME) with outcomes in breast cancer patients treated on the ECOG 2190/Intergroup 0121 (E2190/Int0121) study Journal of Clinical Oncology. 25: 596-596. DOI: 10.1200/Jco.2007.25.18_Suppl.596 |
0.336 |
|
| 2007 |
Adams SF, Levine DA, Zhang L, Barakat R, Boyd J, Gimotty P, Coukos G. Ki67 expression as a predictor for suboptimally debulked patients with advanced epithelial ovarian cancer Journal of Clinical Oncology. 25: 5563-5563. DOI: 10.1200/Jco.2007.25.18_Suppl.5563 |
0.389 |
|
| 2006 |
Ziober AF, Patel KR, Alawi F, Gimotty P, Weber RS, Feldman MM, Chalian AA, Weinstein GS, Hunt J, Ziober BL. Identification of a gene signature for rapid screening of oral squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 5960-71. PMID 17062667 DOI: 10.1158/1078-0432.Ccr-06-0535 |
0.337 |
|
| 2006 |
Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer. 107: 2436-45. PMID 17058288 DOI: 10.1002/Cncr.22295 |
0.399 |
|
| 2006 |
Ross SR, Schmidt JW, Katz E, Cappelli L, Hultine S, Gimotty P, Monroe JG. An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. Journal of Virology. 80: 9000-8. PMID 16940512 DOI: 10.1128/Jvi.00788-06 |
0.302 |
|
| 2006 |
Zhang L, Huang J, Yang N, Liang S, Barchetti A, Giannakakis A, Cadungog MG, O'Brien-Jenkins A, Massobrio M, Roby KF, Katsaros D, Gimotty P, Butzow R, Weber BL, Coukos G. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Research. 66: 4627-35. PMID 16651413 DOI: 10.1158/0008-5472.Can-05-4527 |
0.342 |
|
| 2006 |
Buckanovich RJ, Sasaroli D, O'brien-Jenkins A, Botbyl J, Conejo-Garcia JR, Benencia F, Liotta LA, Gimotty PA, Coukos G. Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer Biology & Therapy. 5: 635-42. PMID 16627987 DOI: 10.4161/Cbt.5.6.2676 |
0.344 |
|
| 2006 |
Karakousis GC, Gimotty PA, Botbyl JD, Kesmodel SB, Elder DE, Elenitsas R, Ming ME, Guerry D, Fraker DL, Czerniecki BJ, Spitz FR. Predictors of regional nodal disease in patients with thin melanomas. Annals of Surgical Oncology. 13: 533-41. PMID 16523360 DOI: 10.1245/Aso.2006.05.011 |
0.341 |
|
| 2006 |
Zhang T, Somasundaram R, Berencsi K, Caputo L, Gimotty P, Rani P, Guerry D, Swoboda R, Herlyn D. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4 European Journal of Immunology. 36: 457-467. PMID 16421945 DOI: 10.1002/Eji.200526208 |
0.378 |
|
| 2006 |
Tuveson DA, Zhu L, Gopinathan A, Willis NA, Kachatrian L, Grochow R, Pin CL, Mitin NY, Taparowsky EJ, Gimotty PA, Hruban RH, Jacks T, Konieczny SF. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Research. 66: 242-7. PMID 16397237 DOI: 10.1158/0008-5472.Can-05-2305 |
0.308 |
|
| 2006 |
Buckanovich RJ, Kim S, Benencia F, Sasaroli D, Gimotty P, Coukos G. Endothelin receptor B predicts poor prognosis in epithelial ovarian cancer (EOC) and can be inhibited to increase intratumoral T cells and enhance tumor vaccine therapy Journal of Clinical Oncology. 24: 2524-2524. DOI: 10.1200/Jco.2006.24.18_Suppl.2524 |
0.388 |
|
| 2006 |
Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR. Members of the glutathione (GSH) and ABC-transporter families are associated with clinical outcomes in patients with diffuse large B-cell lymphoma (DLCL) Journal of Clinical Oncology. 24: 10035-10035. DOI: 10.1200/Jco.2006.24.18_Suppl.10035 |
0.305 |
|
| 2006 |
Andreadis C, Gimotty P, Hammond R, Wahl P, Houldsworth J, Schuster S, Rebbeck T. Expression Levels of Glutathione Peroxidase 1 (GPx1) and Multi-Drug Resistance 1 (MDR1; ABCB1) Identify Patients with Diffuse Large B-Cell Lymphoma (DLBCL) That Have Superior Clinical Outcomes. Blood. 108: 839-839. DOI: 10.1182/Blood.V108.11.839.839 |
0.357 |
|
| 2005 |
Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatologic Therapy. 18: 369-85. PMID 16297012 DOI: 10.1111/J.1529-8019.2005.00044.X |
0.383 |
|
| 2005 |
Gimotty PA, Botbyl J, Soong SJ, Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8065-75. PMID 16258105 DOI: 10.1200/Jco.2005.02.4976 |
0.361 |
|
| 2005 |
Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8048-56. PMID 16258103 DOI: 10.1200/Jco.2005.02.0735 |
0.382 |
|
| 2005 |
Andreadis C, Schuster SJ, Chong EA, Svoboda J, Luger SM, Porter DL, Tsai DE, Nasta SD, Elstrom RL, Goldstein SC, Downs LH, Mangan PA, Cunningham KA, Hummel KA, Gimotty PA, et al. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma. Bone Marrow Transplantation. 36: 955-61. PMID 16205727 DOI: 10.1038/Sj.Bmt.1705178 |
0.321 |
|
| 2005 |
DeMichele A, Aplenc R, Botbyl J, Colligan T, Wray L, Klein-Cabral M, Foulkes A, Gimotty P, Glick J, Weber B, Stadtmauer E, Rebbeck TR. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5552-9. PMID 16110016 DOI: 10.1200/Jco.2005.06.208 |
0.318 |
|
| 2005 |
Kesmodel SB, Karakousis GC, Botbyl JD, Canter RJ, Lewis RT, Wahl PM, Terhune KP, Alavi A, Elder DE, Ming ME, Guerry D, Gimotty PA, Fraker DL, Czerniecki BJ, Spitz FR. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Annals of Surgical Oncology. 12: 449-58. PMID 15864482 DOI: 10.1245/Aso.2005.04.027 |
0.344 |
|
| 2005 |
Zhang T, Somasundaram R, Berencsi K, Caputo L, Rani P, Guerry D, Furth E, Rollins BJ, Putt M, Gimotty P, Swoboda R, Herlyn M, Herlyn D. CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture. Journal of Immunology (Baltimore, Md. : 1950). 174: 5856-63. PMID 15843590 DOI: 10.4049/Jimmunol.174.9.5856 |
0.365 |
|
| 2005 |
Gimotty P, Botbyl J, Kruper L, Guerry D. An improved classification of thin stage I melanomas using AJCC prognostic factors Journal of Clinical Oncology. 23: 7512-7512. DOI: 10.1200/Jco.2005.23.16_Suppl.7512 |
0.329 |
|
| 2004 |
Kelz RR, Gimotty PA, Polsky D, Norman S, Fraker D, DeMichele A. Morbidity and mortality of colorectal carcinoma surgery differs by insurance status. Cancer. 101: 2187-94. PMID 15382089 DOI: 10.1002/Cncr.20624 |
0.304 |
|
| 2004 |
Gimotty PA, Guerry D, Ming ME, Elenitsas R, Xu X, Czerniecki B, Spitz F, Schuchter L, Elder D. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3668-76. PMID 15302909 DOI: 10.1200/Jco.2004.12.015 |
0.352 |
|
| 2004 |
Conejo-Garcia JR, Benencia F, Courreges MC, Gimotty PA, Khang E, Buckanovich RJ, Frauwirth KA, Zhang L, Katsaros D, Thompson CB, Levine B, Coukos G. Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells. Cancer Research. 64: 2175-82. PMID 15026360 DOI: 10.1158/0008-5472.Can-03-2194 |
0.327 |
|
| 2004 |
Gimotty PA, Belle PV, Elder DE, Montone K, Murry T, Elenitsas R, Ming ME, Hotz S, Botbyl JD, Guerry D. Prognostic significance for metastasis of Ki-67 and mitotic rate in cutaneous melanoma Journal of Clinical Oncology. 22: 7516-7516. DOI: 10.1200/Jco.2004.22.90140.7516 |
0.4 |
|
| 2003 |
Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. The New England Journal of Medicine. 348: 203-13. PMID 12529460 DOI: 10.1056/Nejmoa020177 |
0.364 |
|
| 2002 |
Gimotty PA, Guerry D, Elder DE. Validation of prognostic models for melanoma. American Journal of Clinical Pathology. 118: 489-91. PMID 12375633 DOI: 10.1309/Agf8-11Vw-Jlrn-61Uq |
0.35 |
|
| 1996 |
Pauley RJ, Gimotty PA, Paine TJ, Dawson PJ, Wolman SR. INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes. Breast Cancer Research and Treatment. 37: 65-76. PMID 8750529 DOI: 10.1007/Bf01806633 |
0.383 |
|
| 1991 |
Wolman SR, Feiner HD, Schinella RA, Gimotty P, Ownby H, Maloney T, Dawson PJ. A retrospective analysis of breast cancer based on outcome differences. Human Pathology. 22: 475-80. PMID 1674493 DOI: 10.1016/0046-8177(91)90134-B |
0.382 |
|
| 1991 |
Dawson PJ, Maloney T, Gimotty P, Juneau P, Ownby H, Wolman SR. Bilateral breast cancer: one disease or two? Breast Cancer Research and Treatment. 19: 233-44. PMID 1663803 DOI: 10.1007/Bf01961160 |
0.343 |
|
| Show low-probability matches. |